期刊文献+

胰腺癌的流行病学与诊治现状分析 被引量:13

Current status on epidemiology and management of pancreatic cancer
下载PDF
导出
摘要 胰腺癌恶性程度高,手术切除率低,预后极差,其早期症状表现不典型,所以早期诊断较难。我国胰腺癌的发病率呈逐年上升趋势,但目前国内在胰腺癌的诊治中尚存在许多不足,胰腺癌相关的基础研究不够深入。本文对胰腺癌的最新流行病学数据、诊治现状及存在的问题进行了分析,为当下国内胰腺癌的诊疗提供参考。 Pancreatic cancer is the most malignancy with extremely low rate of surgical resection and very poor prognosis. It is difficult to early identify pancreatic cancer due to its insidious symptoms at early stage. The incidence of pancreatic cancer in China has been increasing in recent years. However, there are still many deifciencies in management of pancreatic cancer in China and its relevant basic research has not been done deeply. The updated epidemiological data, present situation of diagnosis and treatments, and the problems were analyzed in this paper. We hope it can provide reference for the diagnosis and treatments of pancreatic cancer in China.
作者 虞先濬 鹿语
出处 《上海医药》 CAS 2014年第10期4-6,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 胰腺癌 诊断 综合治疗 pancreatic cancer diagnosis combined treatment
  • 相关文献

参考文献2

二级参考文献55

  • 1Neoptolemos JP,Stocken DD,Friess H,et al.A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerNew England Journal of Homeopathy,2004.
  • 2Jemal A;Siegel R;Ward E.Cancer statistics,2009,2009.
  • 3Wagner M,Redaelli C,Lietz M,et al.Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. The British Journal of Surgery . 2004
  • 4Shishir K. Maithel MD,Stephen Maloney MD,Corrine Winston MD,Mithat G?nen PhD,Michael I. D’Angelica MD,Ronald P. DeMatteo MD,William R. Jarnagin MD,Murray F. Brennan MD,Peter J. Allen MD.Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma[J]. Annals of Surgical Oncology . 2008 (12)
  • 5Gauri R. Varadhachary MD,Eric P. Tamm MD,James L. Abbruzzese MD,Henry Q. Xiong MD,Christopher H. Crane MD,Huamin Wang MD,Jeffrey E. Lee MD,Peter W. T. Pisters MD,Douglas B. Evans MD,Robert A. Wolff MD.Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy[J]. Annals of Surgical Oncology . 2006 (8)
  • 6Gillen S,Schuster T,Meyer Zum Büschenfelde C,Friess H,Kleeff J.Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med . 2010
  • 7Katz MH,Pisters PW,Evans DB,Sun CC,Lee JE,Fleming JB,Vauthey JN,Abdalla EK,Crane CH,Wolff RA,Varad- hachary GR,Hwang RF.Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. Journal of the American College of Surgeons . 2008
  • 8Michalski CW,Kleeff J,Bachmann J, et al.Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center. Annals of Surgical Oncology . 2008
  • 9Vulfovich M,Rocha-Lima C.Novel advances in pancreatic cancer treatment. Expert Review of Anticancer Therapy . 2008
  • 10C.S. Verbeke,D. Leitch,K.V. Menon,M.J. McMahon,P.J. Guillou,A. Anthoney.Redefining the R1 resection in pancreatic cancer. British Journal of Surgery . 2006

共引文献9

同被引文献144

引证文献13

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部